Cardinal Capital Management buys $738,445 stake in Balchem Corporation (BCPC)

Balchem Corporation (BCPC) : Cardinal Capital Management scooped up 810 additional shares in Balchem Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 11,598 shares of Balchem Corporation which is valued at $738,445.Balchem Corporation makes up approximately 0.30% of Cardinal Capital Management’s portfolio.

Balchem Corporation closed down -1.37 points or -2.13% at $62.92 with 1,06,241 shares getting traded on Wednesday. Post opening the session at $64.01, the shares hit an intraday low of $62.64 and an intraday high of $64.7 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Strs Ohio sold out all of its stake in BCPC during the most recent quarter. The investment firm sold 176,300 shares of BCPC which is valued $11,225,021.Summit Creek Advisors boosted its stake in BCPC in the latest quarter, The investment management firm added 16,841 additional shares and now holds a total of 254,118 shares of Balchem Corporation which is valued at $16,179,693. Balchem Corporation makes up approx 2.50% of Summit Creek Advisors’s portfolio.Independent Portfolio Consultants reduced its stake in BCPC by selling 60 shares or 0.92% in the most recent quarter. The Hedge Fund company now holds 6,450 shares of BCPC which is valued at $401,642. Balchem Corporation makes up approx 0.11% of Independent Portfolio Consultants’s portfolio.Capital Investment Services Of America reduced its stake in BCPC by selling 454 shares or 0.32% in the most recent quarter. The Hedge Fund company now holds 142,382 shares of BCPC which is valued at $8,695,269. Balchem Corporation makes up approx 1.67% of Capital Investment Services Of America’s portfolio.

Many Wall Street Analysts have commented on Balchem Corporation. Balchem Corporation was Downgraded by Sidoti to ” Neutral” on Mar 8, 2016. Balchem Corporation was Upgraded by Sidoti to ” Buy” on Feb 2, 2016.

Balchem Corporation (Balchem) is engaged in the development manufacture distribution and marketing of specialty performance ingredients and products for the food nutritional feed pharmaceutical and medical sterilization industries. The Company operates in three segments: Specialty Products SensoryEffects and Animal Nutrition & Health (ANH). The Company sells its products through its own sales force independent distributors and sales agents. The Specialty Products segment offers Ethylene oxide canisters and propylene oxide. The SensoryEffects segment provides creamer systems dairy replacers powdered fats nutritional beverage bases beverages juice and dairy bases chocolate systems ice cream bases and variegates ready-to-eat cereals grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride and microencapsulation and chelation technologies-based nutritional products.

Leave a Reply

Balchem Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Balchem Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.